*Program and presenters subject to change. Please check back frequently for updates.
Session Leader: Aman Khera, EMBA, FRAPS, FTOPRA (she/her/hers) – Worldwide Clinical Trials
### she/her/hers @@@ Sarah Bly (she/her/hers) – Worldwide Clinical Trials ### 2074800###Presenter###Director, Regulatory Science, Strategy & Innovation###Worldwide Clinical Trials ###Presenter: Sarah Bly (she/her/hers) – Worldwide Clinical Trials
### she/her/hersModerator: Maria A. Apostolaros, JD, PharmD, MS, BSc, RPh, CCEP – PhRMA
### @@@ Robyn Bent, RN, MS (she/her/hers) – FDA ### 1724460###Presenter###FDA/CDER/OCD, Supervisory General Health Scientist###FDA###Presenter: Robyn Bent, RN, MS (she/her/hers) – FDA
### she/her/hers @@@ Josh Coulter, MA (he/him/his) – Pfizer ### 2098133###Presenter###Director, Preference Elicitation###Pfizer###Presenter: Josh Coulter, MA (he/him/his) – Pfizer
### he/him/his @@@ Claire Espinasse ### 2132791###Presenter (Remote)#########Presenter (Remote): Claire Espinasse
### @@@ Nicholas Langevin – Sumitomo Pharma America, Inc. ### 2045398###Presenter###Director, Regulatory Affairs###Sumitomo Pharma America, Inc.###Presenter: Nicholas Langevin – Sumitomo Pharma America, Inc.
###Session Leader: Michelle Lynn Jump, MS, MSRS, ISO/TC 215 convener, RAPS instructor – MEDSEC
### @@@ Suzanne Schwartz, MD, MBA (she/her/hers) – US FDA ### 593621###Presenter (Remote)###Director – Office of Strategic Partnerships & Technology Innovation (OST) at CDRH###US FDA###Presenter (Remote): Suzanne Schwartz, MD, MBA (she/her/hers) – US FDA
### she/her/hers
